Ribomic

Developer of aptamer-based therapeutics for the treatment of multiple diseases

placeChiba, Chiba, Japan calendar_todayFounded 2003 groups25 employees language ribomic.com

Innovation

30 patent families (15 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 1,171 times.

YearFilings
20147
20159
20168
20176
20185
20194
20209
20217
20226
20234
20244
20256

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital686%
Private equity114%
Coming soon